208 related articles for article (PubMed ID: 25876017)
1. Evaluation of near infrared spectroscopy for detecting the β blocker-induced decrease in cerebral oxygenation during hemodilution in a swine model.
Kurita T; Morita K; Sato S
J Clin Monit Comput; 2015 Dec; 29(6):779-88. PubMed ID: 25876017
[TBL] [Abstract][Full Text] [Related]
2. Impact of a β-blocker and/or acute hemodilution on cerebral oxygenation during apneic hypoxia.
Kurita T; Morita K; Sato S
Acta Anaesthesiol Scand; 2016 Mar; 60(3):343-53. PubMed ID: 26806957
[TBL] [Abstract][Full Text] [Related]
3. Use of a Short-Acting β1 Blocker During Endotoxemia May Reduce Cerebral Tissue Oxygenation if Hemodynamics are Depressed by a Decrease in Heart Rate.
Kurita T; Kawashima S; Morita K; Nakajima Y
Shock; 2017 Jun; 47(6):765-771. PubMed ID: 28505021
[TBL] [Abstract][Full Text] [Related]
4. Dobutamine, a β1 Adrenoceptor Agonist, Increases Cerebral Oxygenation During Acute Anemia and Apneic Hypoxia.
Kurita T; Kawashima S; Morita K; Nakajima Y
Neurocrit Care; 2017 Dec; 27(3):420-429. PubMed ID: 28664391
[TBL] [Abstract][Full Text] [Related]
5. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol.
Sasao J; Tarver SD; Kindscher JD; Taneyama C; Benson KT; Goto H
Can J Anaesth; 2001 Nov; 48(10):985-9. PubMed ID: 11698317
[TBL] [Abstract][Full Text] [Related]
6. Acute hemodynamic effects of landiolol, an ultra-short-acting beta-blocker, in patients with acute coronary syndrome: preliminary study.
Hoshi T; Sato A; Nishina H; Kakefuda Y; Wang Z; Noguchi Y; Aonuma K
J Cardiol; 2012 Oct; 60(4):252-6. PubMed ID: 22835733
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Pharmacodynamics of Low-, Intermediate-, and High-Dose Landiolol and Esmolol During Long-Term Infusion in Healthy Whites.
Krumpl G; Ulč I; Trebs M; Kadlecová P; Hodisch J; Maurer G; Husch B
J Cardiovasc Pharmacol; 2018 Mar; 71(3):137-146. PubMed ID: 29112591
[TBL] [Abstract][Full Text] [Related]
8. The effect of esmolol-induced controlled hypotension in combination with acute normovolemic hemodilution on cerebral oxygenation.
Han SH; Bahk JH; Kim JH; Lim YJ; Park CD; Do SH; Park YS
Acta Anaesthesiol Scand; 2006 Aug; 50(7):863-8. PubMed ID: 16879470
[TBL] [Abstract][Full Text] [Related]
9. [New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].
Mio Y
Masui; 2006 Jul; 55(7):841-8. PubMed ID: 16856544
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenoreceptor antagonists attenuate brain injury after transient focal ischemia in rats.
Goyagi T; Kimura T; Nishikawa T; Tobe Y; Masaki Y
Anesth Analg; 2006 Sep; 103(3):658-63. PubMed ID: 16931677
[TBL] [Abstract][Full Text] [Related]
11. Landiolol and esmolol prevent tachycardia without altering cerebral blood flow.
Saito S; Nishihara F; Akihiro T; Nishikawa K; Obata H; Goto F; Yuki N
Can J Anaesth; 2005 Dec; 52(10):1027-34. PubMed ID: 16326671
[TBL] [Abstract][Full Text] [Related]
12. Landiolol, an ultra short-acting beta1-adrenoceptor antagonist, does not alter the minimum alveolar anesthetic concentration of isoflurane in a swine model.
Kurita T; Takata K; Uraoka M; Morita K; Sato S
Anesth Analg; 2007 Sep; 105(3):656-60. PubMed ID: 17717219
[TBL] [Abstract][Full Text] [Related]
13. Modifications of the hemodynamic consequences of theophylline intoxication with landiolol in halothane-anesthetized dogs.
Takahashi S; Fujii Y; Hoshi T; Inomata S; Miyabe M; Toyooka H
Can J Anaesth; 2000 Mar; 47(3):265-72. PubMed ID: 10730740
[TBL] [Abstract][Full Text] [Related]
14. Effects of landiolol on systemic and cerebral hemodynamics and recovery from anesthesia in patients undergoing craniotomy.
Kawaguchi M; Kawaraguchi Y; Yamamoto Y; Hayashi H; Abe R; Inoue S; Nakase H; Furuya H
J Anesth; 2010 Aug; 24(4):503-10. PubMed ID: 20339879
[TBL] [Abstract][Full Text] [Related]
15. Esmolol and landiolol, selective beta1-adrenoreceptor antagonists, provide neuroprotection against spinal cord ischemia and reperfusion in rats.
Umehara S; Goyagi T; Nishikawa T; Tobe Y; Masaki Y
Anesth Analg; 2010 Apr; 110(4):1133-7. PubMed ID: 20103544
[TBL] [Abstract][Full Text] [Related]
16. Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group.
Krumpl G; Ulc I; Trebs M; Kadlecová P; Hodisch J
Eur J Clin Pharmacol; 2017 Apr; 73(4):417-428. PubMed ID: 28091703
[TBL] [Abstract][Full Text] [Related]
17. Landiolol, an ultra-short-acting beta 1-adrenoceptor antagonist, does not alter the electroencephalographic effect of isoflurane in swine model.
Kurita T; Morita K; Fukuda K; Takata K; Uraoka M; Sanjo Y; Sato S
Br J Anaesth; 2006 May; 96(5):602-7. PubMed ID: 16567345
[TBL] [Abstract][Full Text] [Related]
18. Assessment of cerebral oxygenation using near infrared spectroscopy during isovolemic hemodilution in pediatric patients.
Tobias JD
J Clin Monit Comput; 2011 Jun; 25(3):171-4. PubMed ID: 21870164
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of esmolol, an ultrashort-acting beta blocker.
Askenazi J; MacCosbe PE; Hoff J; Turlapaty P; Hua TA; Laddu A
J Clin Pharmacol; 1987 Aug; 27(8):567-73. PubMed ID: 2888793
[TBL] [Abstract][Full Text] [Related]
20. Direct effects of esmolol and landiolol on cardiac function, coronary vasoactivity, and ventricular electrophysiology in guinea-pig hearts.
Shibata S; Okamoto Y; Endo S; Ono K
J Pharmacol Sci; 2012; 118(2):255-65. PubMed ID: 22293301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
